• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆纤连蛋白在体外增强纤溶系统。

Plasma fibronectin enhances fibrinolytic system in vitro.

作者信息

Gilboa N, Kaplan J E

出版信息

Thromb Haemost. 1985 Oct 30;54(3):639-44.

PMID:2935966
Abstract

The effects of plasma fibronectin on the fibrinolytic system were studied in vitro. Fibronectin caused a time and concentration-dependent increase (up to 99% with 330 micrograms/ml) in the amidolytic activity of tissue plasminogen activator (TPA) but not of urokinase. In the presence of fibronectin the Km of the amidolytic activity of TPA decreased without a change in Vmax. It also caused a concentration-dependent increase in lys-plasminogen activation by TPA (up to 825% with 375 micrograms/ml) and by urokinase (up to 400% with 250 micrograms/ml), as well as in the amidolytic activity of plasmin (up to 55% with 300 micrograms/ml). Fibronectin did not enhance the activation of glu-plasminogen. In the presence of fibronectin the Km of lys-plasminogen activation decreased without a change in Vmax. In purified systems fibronectin significantly shortened the clot lysis time (CLT) by up to 28% and 30% in TPA- and plasmin-activated lysis, respectively. The presence of Ca2+ did not change fibronectin's effect on CLT. Clots of non-fibronectin-depleted plasma were lysed up to about twice as fast as the clots of fibronectin-depleted plasma. In conclusion, physiologic concentrations of fibronectin enhanced the fibrinolytic system in vitro. Further studies will be required to elucidate the mechanisms involved and to document whether fibronectin has a similar effect in vivo.

摘要

体外研究了血浆纤连蛋白对纤溶系统的影响。纤连蛋白使组织型纤溶酶原激活剂(TPA)的酰胺水解活性呈时间和浓度依赖性增加(330微克/毫升时增加高达99%),但对尿激酶无此作用。在纤连蛋白存在的情况下,TPA酰胺水解活性的Km降低,而Vmax不变。它还使TPA(375微克/毫升时增加高达825%)和尿激酶(250微克/毫升时增加高达400%)介导的赖氨酸纤溶酶原激活以及纤溶酶的酰胺水解活性(300微克/毫升时增加高达55%)呈浓度依赖性增加。纤连蛋白不会增强谷氨酸纤溶酶原的激活。在纤连蛋白存在的情况下,赖氨酸纤溶酶原激活的Km降低,而Vmax不变。在纯化系统中,纤连蛋白在TPA激活的溶解和纤溶酶激活的溶解中分别使凝块溶解时间(CLT)显著缩短高达28%和30%。Ca2+的存在不会改变纤连蛋白对CLT的影响。未去除纤连蛋白的血浆凝块的溶解速度比去除纤连蛋白的血浆凝块快约两倍。总之,生理浓度的纤连蛋白在体外增强了纤溶系统。需要进一步研究以阐明其中涉及的机制,并证明纤连蛋白在体内是否有类似作用。

相似文献

1
Plasma fibronectin enhances fibrinolytic system in vitro.血浆纤连蛋白在体外增强纤溶系统。
Thromb Haemost. 1985 Oct 30;54(3):639-44.
2
Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.组织型纤溶酶原激活剂(tPA)抑制纤溶酶对纤维蛋白的降解。该机制可减缓tPA介导的纤维蛋白溶解,但不需要α2-抗纤溶酶或内源性纤溶酶原的泄漏。
J Clin Invest. 1995 Jun;95(6):2483-90. doi: 10.1172/JCI117949.
3
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
4
In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.豚鼠角膜细胞组织型纤溶酶原激活剂的纤溶、溶栓和纤维蛋白原溶解特性的体外研究。
Thromb Haemost. 1985 Apr 22;53(2):200-3.
5
Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.凝血酶激活的纤溶抑制物(TAFI)以纤溶酶原激活物浓度依赖的方式影响纤维蛋白溶解。在内源性凝块溶解模型中对七种纤溶酶原激活物的研究。
Thromb Haemost. 2004 Mar;91(3):473-9. doi: 10.1160/TH03-06-0377.
6
Mechanism of action of fibrinolytic enzymes in vivo.纤溶酶在体内的作用机制。
J Med. 1979;10(1-2):99-119.
7
Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.肌动蛋白可通过组织型和尿激酶型纤溶酶原激活剂刺激纤溶酶的生成。
Arch Biochem Biophys. 1993 Nov 15;307(1):138-45. doi: 10.1006/abbi.1993.1572.
8
Influence of homocysteine on fibrin network lysis.同型半胱氨酸对纤维蛋白网络溶解的影响。
Blood Coagul Fibrinolysis. 2006 Apr;17(3):181-6. doi: 10.1097/01.mbc.0000220238.99843.45.
9
Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.锌通过减弱纤溶酶原激活和纤溶酶介导的纤维蛋白降解来延迟血凝块溶解。
Thromb Haemost. 2015 Jun;113(6):1278-88. doi: 10.1160/TH14-09-0771. Epub 2015 Mar 19.
10
Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.深入了解硫酸皮肤素的纤溶活性:对组织型和尿激酶型纤溶酶原激活物介导的纤溶酶原激活的影响。
Thromb Res. 2007;120(5):745-52. doi: 10.1016/j.thromres.2006.12.014. Epub 2007 Jan 31.

引用本文的文献

1
The immunopathology of acute experimental allergic encephalomyelitis. V. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen.急性实验性变应性脑脊髓炎的免疫病理学。V. 纤连蛋白和纤维蛋白原的光镜及超微结构免疫组织化学分析
Am J Pathol. 1988 Jun;131(3):547-58.
2
Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.纤溶酶原激活剂与纤维蛋白的结合:特性及药理学后果
Biochem J. 1989 Jul 15;261(2):313-24. doi: 10.1042/bj2610313.
3
Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.
催化位点和赖氨酸结合位点在纤溶酶诱导的中性粒细胞黏附于内皮细胞中的作用。
J Clin Invest. 1989 Sep;84(3):793-801. doi: 10.1172/JCI114238.
4
Clinical disorders of fibrinolysis: a critical review.纤维蛋白溶解的临床病症:批判性综述。
Blut. 1989 Jul;59(1):1-14. doi: 10.1007/BF00320240.